Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 53 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R37AI095983-07
Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial Disease
French National Research Agency (ANR)
Grant: ANR-16-CE17-0005
Human genetic dissection of Mendelian susceptibility to mycobacterial disease
NIAID NIH HHS
Grant: R37 AI095983
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series
Additional file 1 of Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series
Additional file 2 of Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series
Additional file 2 of Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series